Long-term Outcomes of Laparoscopic Versus Open D3 Dissection for Stage II/III Colon Cancer: Results of Propensity Score Analyses
Overview
Oncology
Affiliations
Background: Non-inferiority of the laparoscopic approach for stage II/III colon cancer has not been clearly established. This study aimed to evaluate the long-term outcomes of laparoscopic versus open D3 surgery.
Methods: Subjects were 1230 consecutive patients with stage II/III colon cancer, who were referred to the National Cancer Center Hospital from 2004 to 2013. Open surgery was performed in 821 (67%) patients, and laparoscopic surgery was performed in 409 (33%). Propensity score analyses with overall survival as the primary endpoint were performed in three different propensity score methods.
Results: Regression adjustment using the propensity score as a linear predictor in the model showed similar overall survival between laparoscopic and open surgeries [hazard ratio (HR), 0.98 (95% CI [0.64-1.46]; p = 0.916)]. Stratification analysis of the entire cohort revealed that, among five strata, only the highest stratum (clinical T2/T3, clinical N0/N1, tumor size <6 cm, and body mass index (BMI) < 28) had an HR of <1 (0.37). In the other four strata, open surgery was favored as reflected by HRs of >1 (1.13-1.26). The propensity score-matched cohort (365 matched pairs), from which patients with advanced disease and high BMI were excluded, yielded an HR of 0.93 (95% CI [0.57-1.52]; p = 0.772).
Conclusions: Laparoscopic surgery appeared to be a safe and reasonable option for patients with stage II/III colon cancer in general. Patients with high BMI, clinical N2 and T4 disease, and tumor size ≥6 cm might require prudent selection of surgical approach.
Conti C, Pedrazzani C, Turri G, Fernandes E, Lazzarini E, De Luca R Ann Coloproctol. 2021; 37(3):166-173.
PMID: 33887816 PMC: 8273717. DOI: 10.3393/ac.2020.05.18.
Wang Y, Wang Y, Wu W, Lu X, An T, Jiang J World J Surg Oncol. 2021; 19(1):102.
PMID: 33827589 PMC: 8028217. DOI: 10.1186/s12957-021-02218-1.
Zhu Z, Wang K, Orangio G, Han J, Lu B, Zhou Z J Gastrointest Oncol. 2020; 11(2):260-268.
PMID: 32399267 PMC: 7212109. DOI: 10.21037/jgo.2020.03.05.
Nakamura Y, Shida D, Tanabe T, Takamizawa Y, Imaizumi J, Ahiko Y Cancer Med. 2019; 9(2):653-662.
PMID: 31799750 PMC: 6970051. DOI: 10.1002/cam4.2758.
Wasmann K, El Klaver C, van der Bilt J, van Dieren S, Nagtegaal I, Ja Punt C Cancer Manag Res. 2019; 11:7141-7157.
PMID: 31534367 PMC: 6681076. DOI: 10.2147/CMAR.S205906.